BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24833097)

  • 1. Tim-3 expression is increased on peripheral T cells from diffuse large B cell lymphoma.
    Xiao T; Zhang L; Chen L; Liu G; Feng Z; Gao L
    Tumour Biol; 2014 Aug; 35(8):7951-6. PubMed ID: 24833097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of PD-1 and TIM-3 on CD3+ T cells from diffuse large B-cell lymphoma.
    Zhang L; Du H; Xiao TW; Liu JZ; Liu GZ; Wang JX; Li GY; Wang LX
    Biomed Pharmacother; 2015 Oct; 75():83-7. PubMed ID: 26463635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3
    Zhang T; Ren T; Song Z; Zhao J; Jiao L; Zhang Z; He J; Liu X; Qiu L; Li L; Zhou S; Meng B; Zhai Q; Ren X; Qian Z; Wang X; Zhang H
    J Immunol Res; 2020; 2020():6968595. PubMed ID: 33178839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of Tim-3
    Zhong W; Liu X; Zhu Z; Li Q; Li K
    Int Immunopharmacol; 2021 Jul; 96():107662. PubMed ID: 33864956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion.
    Huang X; Bai X; Cao Y; Wu J; Huang M; Tang D; Tao S; Zhu T; Liu Y; Yang Y; Zhou X; Zhao Y; Wu M; Wei J; Wang D; Xu G; Wang S; Ma D; Zhou J
    J Exp Med; 2010 Mar; 207(3):505-20. PubMed ID: 20176801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of Tim-3 in peripheral blood of ovarian cancer.
    Wu J; Liu C; Qian S; Hou H
    DNA Cell Biol; 2013 Nov; 32(11):648-53. PubMed ID: 24007284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tim-3 on peripheral CD4⁺ and CD8⁺ T cells is involved in the development of glioma.
    Han S; Feng S; Xu L; Shi W; Wang X; Wang H; Yu C; Dong T; Xu M; Liang G
    DNA Cell Biol; 2014 Apr; 33(4):245-50. PubMed ID: 24512143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma.
    Huang S; Liang C; Zhao Y; Deng T; Tan J; Lu Y; Liu S; Li Y; Chen S
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):143-149. PubMed ID: 33608984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
    Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
    Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Expression of T-Cell Immunoglobulin and Mucin Domain 3 on T Cells from Peripheral Blood in Patients with Cervical Carcinoma.
    Li J; Sun XF; Shen Y; Yang Q; Dai SY
    Gynecol Obstet Invest; 2021; 86(1-2):63-70. PubMed ID: 33279890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Tim-3 as a therapeutic target in prostate cancer.
    Piao YR; Jin ZH; Yuan KC; Jin XS
    Tumour Biol; 2014 Nov; 35(11):11409-14. PubMed ID: 25119597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Tim-3 as a therapeutic target in prostate cancer.
    Piao Y; Jin X
    Tumour Biol; 2017 Jul; 39(7):1010428317716628. PubMed ID: 28681697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid Arthritis.
    Song L; Wang Y; Sui Y; Sun J; Li D; Li G; Liu J; Li T; Shu Q
    Med Sci Monit; 2018 Aug; 24():5660-5667. PubMed ID: 30106887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
    Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
    Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C.
    Osuch S; Laskus T; Berak H; Perlejewski K; Metzner KJ; Paciorek M; Radkowski M; Caraballo Cortés K
    Sci Rep; 2020 Sep; 10(1):16060. PubMed ID: 32994477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection.
    Wu W; Shi Y; Li J; Chen F; Chen Z; Zheng M
    Virol J; 2011 Mar; 8():113. PubMed ID: 21392402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.
    Gao X; Zhu Y; Li G; Huang H; Zhang G; Wang F; Sun J; Yang Q; Zhang X; Lu B
    PLoS One; 2012; 7(2):e30676. PubMed ID: 22363469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.
    Funk CR; Petersen CT; Jagirdar N; Ravindranathan S; Jaye DL; Flowers CR; Langston A; Waller EK
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased exhausted CD8
    Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and function of CD4
    Cha Z; Gu H; Zang Y; Wang Z; Li J; Huang W; Qin A; Zhu L; Tu X; Cheng N; Song H; Qian B
    Int Immunopharmacol; 2018 Aug; 61():132-139. PubMed ID: 29870918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.